Cytokine gene polymorphisms in hepatitis C virus-related oral lichen planus

Experimental Dermatology

Volumn 16, Issue 9, 2007, Pages 730-736

  Carrozzo, Marco ^a,b   Dametto, Ennia ^a   Fasano, Maria Edvige ^a   Arduino, Paolo ^a   Bertolusso, Giorgio ^a   de Capei, Federica Uboldi ^a   Rendine, Sabina ^a   Amoroso, Antonio ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Genes and cytokines; Hepatitis C virus; Oral lichen planus; Polymorphisms

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HETEROZYGOTE; HUMAN; IMMUNOPATHOGENESIS; LICHEN PLANUS; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; UNTRANSLATED REGION;

AGED; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HETEROZYGOTE; HUMANS; INTERFERON TYPE II; ITALY; LICHEN PLANUS, ORAL; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34547895123     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2007.00577.x     Document Type: Article

References (42)

1. Carrozzo M, Gandolfo S. Oral diseases possibly related to hepatitis C virus. Crit Rev Oral Biol Med 2003: 14: 115-127.
2. Lodi G, Giuliani M, Majorana A et al. Lichen planus and hepatitis C virus: A multicentre study of patients with oral lesions and a systematic review. Br J Dermatol 2004: 151: 1172-1181.
3. Weger W, Bauer M, Odell E et al. Role of microchimerism in the pathogenesis of oral lichen planus. Exp Dermatol 2006: 15: 125-129.
4. Thomas D W, Stephens P, Stephens M, Patten D W, Lim S H. T-cell receptor V beta usage by lesional lymphocytes in oral lichen planus. J Oral Pathol Med 1997: 26: 105-109.
5. Carrozzo M, Quadri R, Latorre P et al. Molecular evidence that the hepatitis C virus replicates in the oral mucosa. J Hepatol 2002: 37: 364-369.
6. Lazaro P, Olalquiaga J, Bartolome J et al. Detection of hepatitis C virus RNA and core protein in keratinocytes from patients with cutaneous lichen planus and chronic hepatitis C. J Invest Dermatol 2002: 119: 798-803.
7. Pilli M, Penna A, Zerbini A et al. Oral lichen planus pathogenesis: A role for the HCV-specific cellular immune response. Hepatology 2002: 36: 1446-1452.
8. La Nasa G, Cottoni F, Mulargia M et al. HLA antigen distribution in different clinical subgroups demonstrates genetic heterogeneity in lichen planus. Br J Dermatol 1995: 132: 897-900.
9. Carrozzo M, Francia di Celle P, Gandolfo S et al. Increased frequency of HLA-DR6 allele in Italian patients with hepatitis C virus associated oral lichen planus. Br J Dermatol 2001: 144: 803-808.
10. Carrozzo M, Uboldi de Capei F, Dametto E et al. Tumor necrosis factor-α and interferon-γ polymorphisms contribute to susceptibility to oral lichen planus. J Invest Dermatol 2004: 122: 87-94.
11. Wilson A G, Symons J A, McDowell T L, McDevitt H O, Duff G W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997: 94: 3195-3199.
12. Louis E, Franchimont D, Piron A et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998: 113: 401-406.
13. Perrey C, Pravica V, Sinnott P J, Hutchinson J V. Genotyping for polymorphism in interferon γ, interleukin 10, transforming growth factor β1 and tumour necrosis factor α gene: A technical report. Transpl Immunol 1998: 6: 193-197.
14. Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott P J, Hutchinson I V. In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet 1999: 26: 1-3.
15. Hoffmann S C, Stanley E M, Cox E D et al. Association of cytokine polymorphic inheritance, in vitro cytokine production in anti-CD3/ CD28-stimulated peripheral blood lymphocytes. Transplantation 2001: 72: 1444-1450.
16. Asti M, Martinetti M, Zagaglia C et al. Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease. Hepatology 1999: 29: 1272-1279.
17. Rosen H R, McHutchison J G, Conrad A J et al. Tumor necrosis factor genetic polymorphisms and response to antiviral therapy in patients with chronic hepatitis C. Am J Gastroenterol 2002: 97: 714-720.
18. Knapp S, Hennig B J, Frodsham A J et al. Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection. Immunogenetics 2003: 55: 362-369.
19. Wang Y, Kato N, Hoshida Y et al. Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. Hepatology 2003: 37: 65-71.
20. Carrozzo M, Gandolfo S, Carbone M et al. Hepatitis C virus infection in Italian patients with oral lichen planus: A prospective case-control study. J Oral Pathol Med 1996: 25: 527-533.
21. Simmonds P, Alberti A, Alter H J et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994: 19: 1321-1324.
22. Miller S A, Dykes D D, Polesky H F. A simple salting-out procedure for extraction of DNA from human nucleated cells. Nucleic Acids Res 1988: 16: 221-228.
23. Neben K, Mytilineos J, Moehler T M et al. Polymorphisms of the tumor necrosis factor-alpha gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myeloma. Blood 2002: 100: 2263-2265.
24. Mattiuz P L, Ihde D, Piazza A, Ceppellini R, Bodmer W D M. New approaches to population genetic and segregation analysis of the HLA system. In: Terasaki P I, ed. Histocompatibility Testing. Copenhagen: Munksgaard, 1970: 193-205.
25. Lewontin R C. The interaction of selection and linkage: General considerations of heterotic models. Genetics 1964: 49: 49-67.
26. Kirby A C, Lodi G L, Olsen I, Porter S R. Immunohistochemical and serological comparison of idiopathic and hepatitis C virus-associated forms of oral lichen planus. Eur J Oral Sci 1998: 106: 853-862.
27. Nagao Y, Sata M, Kage M, Kameyama T, Ueno T. Histopathological and immunohistochemical study of oral lichen planus-associated HCV infection. Eur J Intern Med 2000: 11: 277-282.
28. Tilg H, Wilmer A, Vogel W et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992: 103: 264-274.
29. Torre D, Zeroli C, Giola M et al. Serum levels of interleukin-1 alpha, interleukin-1 beta, interleukin-6, and tumor necrosis factor in patients with acute viral hepatitis. Clin Infect Dis 1994: 18: 194-198.
30. Gonzalez-Amaro R, Garcia-Monzon C, Garcia-Buey L et al. Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis. J Exp Med 1994: 179: 841-848.
31. Lohr H F, Schlaak J F, Gerken G, Fleischer B, Dienes H P, Meyer zum Buschenfelde K H. Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology. Liver 1994: 14: 161-166.
32. Koziel M J, Dudley D, Afdhal N et al. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J Clin Invest 1995: 96: 2311-2321.
33. Urata M, Yoshida H, Yanagawa T et al. Interferon activity and its characterization in the sera of patients with premalignant lesions arising in oral mucosa. Int J Oral Maxillofac Surg 1986: 15: 134-147.
34. Yamamoto T, Yoneda K, Ueta E, Hirota J, Osaki T. Serum cytokine levels in patients with oral mucous membrane disorders. J Oral Pathol Med 1991: 20: 275-279.
35. Karagouni E E, Dotsika E N, Sklavounou A. Alteration in peripheral blood mononuclear cell function and serum cytokines in oral lichen planus. J Oral Pathol Med 1994: 23: 28-35.
36. Penna A, Pilli M, Zerbini A et al. Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection. Hepatology 2007: 45: 588-601.
37. Guidotti L G, Chisari F V. Noncytolytic control of viral infections by the innate and adaptive immune response. Ann Rev Immunol 2001: 19: 65-91.
38. Frese M, Schwarzle V, Barth K et al. Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology 2002: 35: 694-703.
39. Sobue S, Nomura T, Ishikawa T et al. Th1/Th2 cytokine profiles and their relationship to clinical features in patients with chronic hepatitis C virus infection. J Gastroenterol 2001: 36: 544-551.
40. Battegay M, Fikes J, Di Bisceglie A M et al. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J Virol 1995: 69: 2462-2470.
41. Knobler H, Zhornicky T, Sandler A, Haran N, Ashur Y, Schattner A. Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association. Am J Gastroenterol 2003: 98: 2751-2756.
42. Lecube A, Hernandez C, Genesca J, Simo R. Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: A case-control study. Diabetes Care 2006: 29: 1096-1101.